Cottonseed Oil: Clinical Trials

5 trials of Cottonseed Oil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated. 3 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Completed 1
Phase 22Completed 1, Terminated 1

Follow Cottonseed Oil: new trials by email Literature Review of Cottonseed Oil trials Research Report on Cottonseed Oil

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Healthy Diets With Plant Oils on Heart and Metabolic Health
Healthy Dietary Pattern with Cottonseed Oil, Healthy Dietary Pattern with Fatty Acid-Matched Plant Oils, Healthy Dietary Pattern with PUFA:SFA Ratio-Matched Plant Oil - Cardiovascular Diseases
Not applicableRecruitingPenn State University522024-09-092026-02-02
Cottonseed Oil Versus Matched PUFA Effects
COTTONSEED OIL, MATCHED PUFA DIET, CONTROL - Dyslipidemia, Overweight and Obesity
Not applicableRecruitingUniversity of Georgia902024-08-312026-09-09
Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
RPh201 Cohort A, Placebo Cohort A, RPh201 Cohort B - Nonarteritic Anterior Ischemic Optic Neuropathy
Phase 2TerminatedRegenera Pharma Ltd1652018-07-102020-10-12
Oil Consumption and Cholesterol
Cottonseed Oil, Olive Oil - Hypercholesterolemia
Not applicableCompletedUniversity of Georgia1122018-05-142023-05-10
A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease
RPh201, Placebo - Mild to Moderate Dementia Due to Alzheimer's Disease, With or Without Coexisting Cerebrovascular Disease
Phase 2CompletedRegenera Pharma Ltd832018-03-012020-04-30

Conditions studied

Alzheimer Disease (1)  ·  Cardiovascular Diseases (1)  ·  Dementia (1)  ·  Dyslipidemias (1)  ·  Hypercholesterolemia (1)  ·  Obesity (1)  ·  Optic Neuropathy, Ischemic (1)  ·  Overweight (1)

Sponsors

Regenera Pharma Ltd (2)  ·  University of Georgia (2)  ·  Penn State University (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Jamie Cooper, PhD (1)  ·  Leonard A Levin, M.D., Ph.D. (1)  ·  Sharon Cohen, MD (1)

Results publications

PMID 35511204, PMID 36056703, PMID 36427543, PMID 38295507